Ayurvedic Management of Vataja Abhishyanda i.e Allergic Conjunctivitis

Management Of Vataja Abhishyanda (Allergic Conjunctivitis) With Gutika Anjana And Punarnavadi Eye Drops A Comparative Clinical Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012159

Enrollment

100

Registered

2018-02-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having itching burning sensation discharge headache i.e Allergic conjunctivitis

Interventions

Intervention1: Group A Punarnavadi eyedrops: one drop each eye 4 times a day for 8 weeks Control Intervention1: Group B Gutika Anjana: 60mg per day in two divided doses both eyes for 8 weeks

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients willing for the treatment 2 Patients between 18 to 50 years of age irrespective of sex caste and religion 3 Patients presenting with signs and symptoms like Toda ( Pricking pain) Stambha (Stiffness of lids) Sangharsha (Foreign body sensation) Parushya (Dryness sign) Shiroabhitapa(Headache) Vishushka Bhava (Dryness feeling) Shishirasruta (Cold lacrimation) Achchasruta (clean watery discharge) Alpa Shopha (Mild chemosis) and on examination hyperaemia swelling follicle and papillae in palpebral and hyperaemia and chemosis in bulbar conjunctiva will be diagnosed as Vataja Abhishyanda (Allergic Conjunctivitis)

Exclusion criteria

Exclusion criteria: 1 Patients below 18 years and above 50 years 2 Patients having complications of corneal involvement like marginal corneal ulcer dacryocystites trachoma keratoconjunctivitis etc other types of allergic conjunctivitis like giant papillary conjunctivitis etc Infective conjunctivitis nonspecific systemic infections patients of ocular trauma uncontrolled diabetes mellitus patients having genetic predisposition to allergy

Design outcomes

Primary

Measure	Time frame
Management of Allergic conjunctivitisTimepoint: 2 months	—

Secondary

Measure	Time frame
Achieve normal conjunctival epitheliumTimepoint: 2 months	—

Countries

India

Contacts

Public ContactDr D B Vaghela

IPGT and RA Jamnagar

drvaghela@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026